| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/05/2013 | US8367605 Copolymer-1 improvements in compositions of copolymers |
| 02/05/2013 | US8366749 Method for interconnecting longitudinal members extending along a spinal column |
| 02/05/2013 | CA2521464C Irna conjugates |
| 02/05/2013 | CA2352454C Peptide-based vaccine for influenza |
| 01/29/2013 | US8362017 N-[5-chloro-2-(methyloxy)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]oxy}acetamide; antiproliferative agents; protein kinase inhibitors; drug screening |
| 01/29/2013 | US8361987 DNA vaccines encoding heat shock proteins |
| 01/29/2013 | US8361723 Keratin 8 mutations are risk factors for developing liver disease of multiple etiologies |
| 01/29/2013 | CA2541425C Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 01/24/2013 | US20130023838 Ocular drug delivery device |
| 01/24/2013 | US20130023561 Facially Amphiphilic Polymers and Oligomers and Uses Thereof |
| 01/24/2013 | US20130023485 Parenteral formulations of peptides for the treatment of systematic lupus erythematosus |
| 01/23/2013 | EP2548880A2 Compositions for increasing telomerase activity |
| 01/23/2013 | EP2158900B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 01/22/2013 | CA2537812C C-met modulators and method of use |
| 01/22/2013 | CA2536735C Methods for determining cd8+ t-cell epitopes |
| 01/16/2013 | CN102875680A Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 01/16/2013 | CN102875413A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 01/15/2013 | US8354507 humanized monoclonal antibodies; complementarity determining region of murine monoclonal antibody heavy chain variable domain operably fused to human heavy chain framework domain; induce apoptosis in HLA-DR-expressing tumor cells |
| 01/15/2013 | CA2451296C Cosmetic method and composition for enhancing attractiveness |
| 01/10/2013 | US20130011458 Anti-virus hydrophilic polymeric material |
| 01/10/2013 | US20130011433 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011389 Compositions and methods for treating coagulation related disorders |
| 01/09/2013 | CN1876657B Stabilization of macrolides |
| 01/09/2013 | CN102861004A Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 01/08/2013 | US8349321 Immunoglobulin formulation and method of preparation thereof |
| 01/08/2013 | US8349311 Mutant interleukin-2 (IL-2) polypeptides |
| 01/08/2013 | CA2531118C Multivalent carriers of bi-specific antibodies |
| 01/08/2013 | CA2527420C Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 01/08/2013 | CA2521987C Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/02/2013 | EP2540302A1 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2540301A2 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | CN101444511B Low dose entecavir formulation and use |
| 01/01/2013 | US8343937 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/01/2013 | US8343936 Antibacterial agents |
| 01/01/2013 | US8343910 Reversible pegylated drugs |
| 01/01/2013 | US8343513 Mixture of polymer and drug with acid adjuvant |
| 01/01/2013 | US8343496 Anti-CD74 immunoconjugates and methods |
| 01/01/2013 | US8343484 Methods for increasing lactose and fructose digestion |
| 12/27/2012 | US20120329783 Compositions and methods for selective inhibition of nicotine acetylcholine receptors |
| 12/27/2012 | US20120329766 Formulation |
| 12/27/2012 | US20120329671 Methods of identifying obm modulators |
| 12/27/2012 | US20120328699 Method and composition for treatment of skeletal dysplasias |
| 12/27/2012 | US20120328614 Immunoglobulin Formulation and Method of Preparation Thereof |
| 12/27/2012 | US20120328559 Compositions and Methods for Treating Inflammatory Lung Disease |
| 12/26/2012 | EP2537524A2 Treatment of T-cell mediated diseases |
| 12/26/2012 | CN1826333B Diamine derivatives |
| 12/25/2012 | US8338583 Snornai-small nucleolar RNA degradation by RNA interference in trypanosomatids |
| 12/25/2012 | US8338475 Anti-proliferative pharmaceutical composition |
| 12/25/2012 | US8338381 Composition and method for the treatment of eye disease |
| 12/25/2012 | US8338180 Using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds |
| 12/25/2012 | US8337861 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 12/25/2012 | US8337855 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 12/20/2012 | US20120322891 Retinoid replacements and opsin agonists and methods for the use thereof |
| 12/20/2012 | US20120322667 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| 12/19/2012 | EP2535042A1 Oral sustained-release composition comprising a macrolide |
| 12/19/2012 | CN101301475B Peg化因子vii糖型 Peg factor vii sugar type |
| 12/18/2012 | CA2671776C Gal3 receptor antagonists for the treatment of depression |
| 12/18/2012 | CA2517517C P38 inhibitors and methods of use thereof |
| 12/13/2012 | WO2005046613A3 Methods and compositions for the treatment of b cell lymphomas and other cancers |
| 12/13/2012 | US20120316219 Modulation of apolipoprotein(a) expression |
| 12/13/2012 | US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 12/13/2012 | US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 12/13/2012 | US20120315344 Cosmetic Compositions and Methods for Using Same to Improve the Aesthetic Appearance of Skin |
| 12/13/2012 | US20120315302 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 12/11/2012 | US8329680 Formulation |
| 12/11/2012 | US8329169 Methods and compositions for the prevention and treatment of sepsis |
| 12/11/2012 | US8329164 Methods and compositions concerning poxviruses and cancer |
| 12/11/2012 | CA2524534C Methods and compositions for the prevention and treatment of sepsis |
| 12/11/2012 | CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 12/06/2012 | US20120309836 Methods and compositions for administration of trpv1 agonists |
| 12/06/2012 | US20120309717 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 12/06/2012 | US20120309712 Compositions Comprising Dietary Fat Complexer and Methods for Their Use |
| 12/06/2012 | US20120308583 Use of gcc ligands |
| 12/05/2012 | EP2530157A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 12/05/2012 | EP2529758A2 Vitamin receptor binding drug delivery conjugates |
| 12/05/2012 | EP2529730A1 Oral sustained-release composition |
| 12/05/2012 | CN1893977B Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 12/05/2012 | CN102120031B Pharmaceutical compositions and methods for accelerating wound healing |
| 12/04/2012 | US8324379 Prodrugs of heteroaryl compounds |
| 12/04/2012 | US8324187 Stabilized formulations of phosphatidylserine |
| 12/04/2012 | US8324167 Treatment of T-cell mediated diseases |
| 12/04/2012 | US8323691 Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms |
| 12/04/2012 | CA2675724C Oral extended-release composition |
| 12/04/2012 | CA2538078C Rifalazil formulations |
| 12/04/2012 | CA2495570C Immunostimulatory compositions and methods of stimulating an immune response |
| 11/29/2012 | US20120302557 Biologically active methylene blue derivatives |
| 11/28/2012 | EP2526958A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 11/28/2012 | EP2526953A1 Methods and pharmaceutical compositions for healing wounds |
| 11/28/2012 | EP2526952A1 Methods and pharmaceutical compositions for healing wounds |
| 11/28/2012 | EP2526940A2 Compositions containing enantiomeric equol, and methods for their making |
| 11/27/2012 | US8318808 Zn2+chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors |
| 11/27/2012 | US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 11/27/2012 | US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 11/27/2012 | US8318175 Method for treating amyloid disease |
| 11/27/2012 | US8318133 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications |
| 11/27/2012 | CA2536954C C-kit modulators and methods of use |
| 11/27/2012 | CA2519249C Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 11/22/2012 | US20120295980 Compounds and methods for delivery of prostacyclin analogs |
| 11/22/2012 | US20120295840 Treatment of aspergillus infections with alpha thymosin peptides |